Safety and Efficacy of Itraconazole Compared to Amphotericin B as Empirical Antifungal Therapy for Neutropenic Fever in Patients with Haematological Malignancy* | Zendy

Ulrich S. Schuler | Zendy; Susanne Bammer | Zendy; Walter E. Aulitzky | Zendy; Claudia R. Binder | Zendy; Angelika Böhme | Zendy; Gerlinde Egerer | Zendy; Michael Sandherr | Zendy; Rainer Schwerdtfeger | Zendy; Gerda Silling | Zendy; Hannes Wandt | Zendy; Axel Glasmacher | Zendy; Gerhard Ehninger | Zendy

Open Access

Safety and Efficacy of Itraconazole Compared to Amphotericin B as Empirical Antifungal Therapy for Neutropenic Fever in Patients with Haematological Malignancy*

Author(s) -

Ulrich S. Schuler,

Susanne Bammer,

Walter E. Aulitzky,

Claudia R. Binder,

Angelika Böhme,

Gerlinde Egerer,

Michael Sandherr,

Rainer Schwerdtfeger,

Gerda Silling,

Hannes Wandt,

Axel Glasmacher,

Gerhard Ehninger

Publication year - 2007

Publication title -

oncology research and treatment

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.553

H-Index - 48

eISSN - 2296-5262

pISSN - 2296-5270

DOI - 10.1159/000100055

Subject(s) - itraconazole , tolerability , medicine , adverse effect , discontinuation , amphotericin b , amphotericin b deoxycholate , neutropenia , gastroenterology , chemotherapy , pharmacology , surgery , antifungal , dermatology , caspofungin

Safety, tolerability and efficacy of itraconazole and amphotericin B (AMB) were compared for empirical antifungal treatment of febrile neutropenic cancer patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research